ANEMIA; HEMODIALYSIS DEPENDENT CHRONIC KIDNEY DISEASE
Clinical trials for ANEMIA; HEMODIALYSIS DEPENDENT CHRONIC KIDNEY DISEASE explained in plain language.
Never miss a new study
Get alerted when new ANEMIA; HEMODIALYSIS DEPENDENT CHRONIC KIDNEY DISEASE trials appear
Sign up with your email to follow new studies for ANEMIA; HEMODIALYSIS DEPENDENT CHRONIC KIDNEY DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New anemia pill challenges standard shot for dialysis patients
Disease control CompletedThis study tested a new drug called MT-6548 against a standard treatment (darbepoetin alfa) for anemia in people on dialysis for chronic kidney disease. About 323 participants in Japan received either the new drug or the standard one to see if it worked as well at keeping hemoglo…
Matched conditions: ANEMIA; HEMODIALYSIS DEPENDENT CHRONIC KIDNEY DISEASE
Phase: PHASE3 • Sponsor: Tanabe Pharma Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New pill could help dialysis patients fight anemia without needles
Disease control CompletedThis phase 3 trial tested an oral drug called vadadustat (MT-6548) in 24 Japanese adults on hemodialysis who had anemia due to chronic kidney disease. The goal was to see if the drug could raise and maintain healthy hemoglobin levels safely. Participants took the tablet daily, an…
Matched conditions: ANEMIA; HEMODIALYSIS DEPENDENT CHRONIC KIDNEY DISEASE
Phase: PHASE3 • Sponsor: Tanabe Pharma Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC